Nathan Thomas Georgette, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Shock | 3 | 2023 | 318 | 2.160 |
Why?
|
Wounds and Injuries | 5 | 2023 | 2400 | 1.510 |
Why?
|
Erythema Nodosum | 1 | 2020 | 30 | 0.750 |
Why?
|
Mediastinal Diseases | 1 | 2020 | 89 | 0.710 |
Why?
|
Blood Coagulation Disorders | 1 | 2023 | 337 | 0.710 |
Why?
|
Lymphadenitis | 1 | 2020 | 98 | 0.700 |
Why?
|
Shock, Septic | 1 | 2023 | 775 | 0.560 |
Why?
|
Wounds, Nonpenetrating | 1 | 2022 | 794 | 0.530 |
Why?
|
Medication Adherence | 2 | 2017 | 2063 | 0.510 |
Why?
|
Injury Severity Score | 3 | 2023 | 1014 | 0.510 |
Why?
|
Fever | 1 | 2020 | 1616 | 0.430 |
Why?
|
Dyspnea | 1 | 2020 | 1303 | 0.420 |
Why?
|
Antiretroviral Therapy, Highly Active | 2 | 2017 | 1873 | 0.380 |
Why?
|
Sepsis | 1 | 2023 | 2593 | 0.330 |
Why?
|
Immunity, Herd | 1 | 2009 | 44 | 0.330 |
Why?
|
Resuscitation | 2 | 2023 | 658 | 0.300 |
Why?
|
Blood Transfusion | 2 | 2023 | 1301 | 0.270 |
Why?
|
Developing Countries | 1 | 2016 | 2815 | 0.240 |
Why?
|
Anti-HIV Agents | 2 | 2016 | 4256 | 0.230 |
Why?
|
Patient Acceptance of Health Care | 1 | 2016 | 3022 | 0.220 |
Why?
|
HIV Infections | 3 | 2017 | 16718 | 0.200 |
Why?
|
South Africa | 2 | 2017 | 1731 | 0.200 |
Why?
|
Itraconazole | 1 | 2020 | 43 | 0.190 |
Why?
|
Retrospective Studies | 7 | 2023 | 77449 | 0.170 |
Why?
|
Disease Outbreaks | 1 | 2009 | 1772 | 0.170 |
Why?
|
Mediastinum | 1 | 2020 | 267 | 0.170 |
Why?
|
Child | 6 | 2023 | 77709 | 0.160 |
Why?
|
Trauma Centers | 1 | 2023 | 890 | 0.160 |
Why?
|
Child, Preschool | 4 | 2023 | 41006 | 0.150 |
Why?
|
Fluid Therapy | 1 | 2021 | 593 | 0.140 |
Why?
|
Temperature | 1 | 2023 | 2206 | 0.140 |
Why?
|
Triage | 1 | 2023 | 976 | 0.140 |
Why?
|
Posture | 1 | 2020 | 958 | 0.130 |
Why?
|
Antifungal Agents | 1 | 2020 | 730 | 0.130 |
Why?
|
Prednisone | 1 | 2020 | 1574 | 0.130 |
Why?
|
Leg | 1 | 2020 | 1116 | 0.130 |
Why?
|
Interview, Psychological | 1 | 2016 | 812 | 0.110 |
Why?
|
Glucocorticoids | 1 | 2020 | 2107 | 0.100 |
Why?
|
Heart Rate | 1 | 2022 | 4091 | 0.090 |
Why?
|
Lymph Nodes | 1 | 2020 | 3474 | 0.080 |
Why?
|
Measles Vaccine | 1 | 2009 | 76 | 0.080 |
Why?
|
Drug Resistance, Viral | 1 | 2013 | 820 | 0.080 |
Why?
|
Program Evaluation | 1 | 2017 | 2488 | 0.080 |
Why?
|
Hospital Mortality | 1 | 2022 | 5317 | 0.080 |
Why?
|
Humans | 10 | 2023 | 744343 | 0.070 |
Why?
|
Measles | 1 | 2009 | 168 | 0.070 |
Why?
|
Emergency Service, Hospital | 2 | 2023 | 7659 | 0.070 |
Why?
|
Blood Pressure | 1 | 2022 | 8554 | 0.070 |
Why?
|
Immunization Programs | 1 | 2009 | 260 | 0.070 |
Why?
|
Diagnosis, Differential | 1 | 2020 | 12959 | 0.060 |
Why?
|
Adolescent | 3 | 2022 | 85781 | 0.060 |
Why?
|
Mutation, Missense | 1 | 2013 | 2564 | 0.060 |
Why?
|
Odds Ratio | 1 | 2016 | 9849 | 0.060 |
Why?
|
Lung | 1 | 2020 | 9856 | 0.050 |
Why?
|
Adult | 4 | 2022 | 214055 | 0.050 |
Why?
|
Infant | 1 | 2022 | 35136 | 0.040 |
Why?
|
Male | 4 | 2021 | 350118 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 1 | 2020 | 20129 | 0.040 |
Why?
|
Vaccination | 1 | 2009 | 3278 | 0.040 |
Why?
|
HIV-1 | 1 | 2013 | 6939 | 0.030 |
Why?
|
Female | 4 | 2021 | 380194 | 0.020 |
Why?
|
Botswana | 1 | 2013 | 1040 | 0.020 |
Why?
|
Withholding Treatment | 1 | 2013 | 599 | 0.020 |
Why?
|
Algorithms | 1 | 2009 | 13881 | 0.020 |
Why?
|
Length of Stay | 1 | 2021 | 6309 | 0.020 |
Why?
|
Infectious Disease Transmission, Vertical | 1 | 2013 | 1320 | 0.020 |
Why?
|
Logistic Models | 1 | 2021 | 13408 | 0.020 |
Why?
|
Middle Aged | 1 | 2017 | 213383 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2013 | 4803 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2013 | 18111 | 0.010 |
Why?
|
Genotype | 1 | 2013 | 12951 | 0.010 |
Why?
|
Pregnancy | 1 | 2013 | 29144 | 0.010 |
Why?
|